Χώρα: Ηνωμένο Βασίλειο
Γλώσσα: Αγγλικά
Πηγή: VMD (Veterinary Medicines Directorate)
Chlamydophila felis, Feline calicivirus, Feline leukemia virus, Feline panleukopenia virus, Feline viral rhinotracheitis virus
Zoetis UK Limited
QI06AL01
Chlamydophila felis, Feline calicivirus, Feline leukemia virus, Feline panleukopenia virus, Feline viral rhinotracheitis virus
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cats
Inactivated Viral and Bacterial Vaccine
Authorized
1997-02-05
Issued: May 2022 AN: 02508/2021 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Fevaxyn Pentofel, suspension for injection for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 1 ml (single dose syringe): ACTIVE COMPONENTS RELATIVE POTENCY (R.P.) Inactivated feline panleucopenia virus, strain CU4 Inactivated feline calicivirus, strain 255 Inactivated feline rhinotracheitis virus, strain 605 Inactivated _Chlamydophila felis_,_ _strain_ _Cello Inactivated feline leukaemia virus, strain 61E ≥ 8.50 ≥ 1.26 ≥ 1.39 ≥ 1.69 ≥ 1.45 ADJUVANTS Ethylene/maleic anhydride (EMA-31) Neocryl Emulsigen SA 1% (v/v) 3% (v/v) 5% (v/v) For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suspension for injection. Vaccine appearance is a pale milky pink liquid which should be free from solid particles. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the active immunisation of healthy cats 9 weeks or older against feline panleucopenia and feline leukaemia viruses and against respiratory diseases caused by feline rhinotracheitis virus, feline calicivirus and _Chlamydophila felis._ Issued: May 2022 AN: 02508/2021 Page 2 of 5 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Vaccination does not affect the course of feline leukaemia virus (FeLV) infection in cats already infected with FeLV at the time of vaccination, implying that such cats will excrete FeLV irrespective of vaccination; consequently, these animals will constitute a hazard to susceptible cats in their environment. It is therefore recommended that cats with a significant risk of having been exposed to FeLV be tested for FeLV antigen prior to vaccination. Test negative animals can be vaccinated, while test-positive cats should be isolated from other cats and retested within 1–2 months. Cats positive at the second testing should be considered as being permanently infected with FeLV and should be handled accordin Διαβάστε το πλήρες έγγραφο